Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها

Drug utilization evaluation of meropenem: an important broad-spectrum antibiotic for the treatment of serious bacterial infections in hospitalized patients

Year: 1396
COI: JR_TIPS-3-1_005
Language: EnglishView: 201
This Paper With 6 Page And PDF Format Ready To Download

Buy and Download

با استفاده از پرداخت اینترنتی بسیار سریع و ساده می توانید اصل این Paper را که دارای 6 صفحه است به صورت فایل PDF در اختیار داشته باشید.
آدرس ایمیل خود را در کادر زیر وارد نمایید:


farzaneh foroughinia - Clinical Pharmacy Department, School of pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran
Seyed Mohammadreza Hashemian - Nursing and Respiratory Health Management Research Center, NRITLD, Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fanak Fahimi - Clinical Pharmacy Department, School of pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.


Increasing trend in the development of antibiotic resistance is one the major concerns of health care systems throughout the world. Several factors are responsible of the emergence of this problem of which frequent inappropriate uses of antimicrobial agents plays an important role. Therefore, in the study we aimed to assess the appropriateness of the usage of meropenem, a broad-spectrum antibiotic, in a teaching affiliated hospital.This study is an observational prospective research on drug utilization. All patients admitted to Masih Daneshvari hospital that had received meropenem during Jun to July 2011 were enrolled in the study. To evaluate the appropriate use of meropenem, an institutional standard guideline was designed by pharmacy and therapeutic committee using evidence-based guidelines. Prescriptions were considered appropriate if they were compliant with the guideline.  The total number of meropenem vials used during this period was 2153 vials. Most prescriptions started empirically (85.9%). Of these, 16.9% of prescriptions continued according to lab results whereas 69% of meropenem courses remained empirical. Our results showed that meropenem was started appropriately in 64.8% of patients whereas just 74.3% of patients received the drug for an adequate duration.In conclusion, our study and several other surveys detected various areas of inappropriate use of broad-spectrum antiobiotics such as meropenem. With regard to the important role of these drugs in the treatment of serious nosocomial infections, a combination of both restrictive and educational measures appears to be necessary to improve rational antibiotic usage as well as to decrease in the frequency of antibiotic resistant.


Paper COI Code

This Paper COI Code is JR_TIPS-3-1_005. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
foroughinia, farzaneh and Hashemian, Seyed Mohammadreza and Fahimi, Fanak,1396,Drug utilization evaluation of meropenem: an important broad-spectrum antibiotic for the treatment of serious bacterial infections in hospitalized patients,

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :

  • Marcus EL, Clarfield AM, Moses AE. Ethical issues relating to ...
  • Roark MK, Reed WE Jr. Econotherapeutics. Diagn. Microbiol. Diagn Microbiol ...
  • Yinnon AM, Skorohod Y, Schlesinger Y, Greenberg A. Cefuroxime utilization ...
  • Gupta LC, Gupta CK, Jain BB, Garg MG. ABC and ...
  • Mohr JF 3rd. Update on the efficacy and tolerability of ...
  • McEvoy GK, ed in chief, Snow ED, ed. AHFS: Drug ...
  • Balderson BJ, Yates ME, Patil NP, Suda KJ. Evaluation of ...
  • Kollef M, Niederman M. Antimicrobial resistance in the ICU: The ...
  • Mladenovic-Antic S, Kocic B, Velickovic-Radovanovic R, Dinic M, Petrovic J, ...
  • Gould IM, Jappy B. Trends in hospital antibiotic prescribing after ...
  • Tarcea Bizo P, Dumitras D, Popa A. Evaluation of restricted ...
  • Thuong M, Shortgen F, Zazempa V, Girou E, Soussy CJ, ...
  • Raveh D, Muallem-Zilcha E, Greenberg A, Wiener-Well Y, Schlesinger Y, ...
  • Khan MU, Yousuf RI, Shoaib MH. Drug utilization evaluation of ...
  • Anglim AM, Klym B, Byers K. E, Scheld WM, Farr ...
  • Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, ...
  • Lew KY, Ng TM, Tan M, Tan SH, Lew EL, ...

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.


The specifications of the publisher center of this Paper are as follows:
Type of center: دانشگاه دولتی
Paper count: 21,774
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.